The Importance of a Physician-Led Program There is a growing number of online programs offering GLP-1 medications with minimal oversight
There are benefits and downsides to switching from Wegovy injections to Wegovy tablets
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
Additionally, a case report highlighted that liraglutide therapy, in contrast to insulin, reduced C-peptide (CPR) concentrations and improved glucose control, along with enhanced quality of life for a patient with T2DM and active CD [228]